Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/INO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Inovio Pharmaceuticals Inc (INO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

INO trades at $1.175, up 0.43% with a bearish technical signal despite recent earnings beats. The company shows minimal revenue of $65K against high SG&A expenses, resulting in a net income margin of -130,000%. Cash flow remains negative at -$21.54M, though improving from previous years. Key catalyst is the October 30 FDA decision for INO-3107, with analyst consensus bullish at a $2.75 price target.
Outlook hinges on FDA approval for INO-3107, offering significant upside if successful. However, extreme financial losses and cash burn pose substantial risks. Institutional sentiment is mixed with 59% buy ratings, but technical indicators suggest caution. Investors should weigh regulatory success against persistent profitability challenges.
Read full analysis

Key Stats

  • Market Cap
    $114.77M
  • Volume
    3,016,393
  • Sector
    Health
  • 52W High
    $2.65
  • 52W Low
    $0.66
  • Typical Hold Time
    42 Days
  • Enterprise Value
    $86.10M
  • Div Yield
    -
  • Trading Activity
    55% Sell | 45% Buy
$1.23
52W Low: $0.66
30 Jul 2026
52W High: $2.65
09 Oct 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.65, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Most Recent News

Content is generated by Aura AI

Class action lawsuit filed against Better Home & Finance over misleading statements on funding targets.

Rosen Law Firm has filed a class action lawsuit against Better Home & Finance Holding Company for allegedly making false and misleading statements about its $1 billion monthly funded volume target during March to May 2026. The lawsuit claims the comp...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
Class action lawsuit filed against Better Home & Finance over misleading statements on funding targets.

Royce Global Trust fund shows strong long-term growth with 21.7% one-year return on small- and mid-cap stocks.

Royce Global Trust, a closed-end fund focusing on global small- and mid-cap equities using a value approach, reported a one-year total return of 21.7% as of August 31, 2026. The fund invests at least 80% of its assets in equity securities, with a sig...

Market News
4 hours ago
PRNewsWire
Neutral
Royce Global Trust fund shows strong long-term growth with 21.7% one-year return on small- and mid-cap stocks.

Royce Micro-Cap Trust posts strong returns with 44.75% one-year NAV growth.

Royce Micro-Cap Trust, a closed-end fund investing in companies with market caps under $1 billion, reported a one-year net asset value (NAV) return of 44.75% as of August 31, 2026. The fund focuses on small- and micro-cap stocks, which carry higher r...

Market News
4 hours ago
PRNewsWire
Neutral
Royce Micro-Cap Trust posts strong returns with 44.75% one-year NAV growth.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $114.77M
  • Volume
    3,016,393
  • Sector
    Health
  • 52W High
    $2.65
  • 52W Low
    $0.66
  • Typical Hold Time
    42 Days
  • Enterprise Value
    $86.10M
  • Div Yield
    -
  • Trading Activity
    55% Sell | 45% Buy
$1.23
52W Low: $0.66
30 Jul 2026
52W High: $2.65
09 Oct 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.65, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!